StockData
Inmune Bio, Inc. logo

Inmune Bio, Inc. (INMB) stock

INMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.96+0.01 (+1.44%)

Close on Nov 17, 2026Market cap $26.64MP/E –Yield –

Inmune Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Inmune Bio's price to sales ratio was 468.9× on Oct 31, 2023, against 466.6× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Oct 31, 2023468.9×+210.3
2022Dec 30, 2022258.6×–

More Inmune Bio figures

See a number that looks wrong?